Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5results about How to "High target accuracy" patented technology

A bacterial active material responsive to colon cancer microenvironment and its preparation method and application

The present invention discloses a bacterial active material that responds to the microenvironment of colon cancer, and a preparation method and application thereof. The method comprises: wrapping hyaluronic acid on a Cu2O precursor to obtain a Cu2O precursor with a negative surface charge; modifying the surface of Eubacterium hallii with polyacrylamine hydrochloride to obtain a Eubacterium hallii solution with a positive surface charge; combining the Cu2O precursor with a negative surface charge and the Eubacterium hallii solution with a positive surface charge through electrostatic action to obtain a hybrid material of bacteria and the Cu2O precursor. The material can accurately respond to the microenvironment of colon cancer, remove H2S, metabolize lactic acid, and in situ generate CuS with a chemokinetic therapeutic effect, thereby realizing a multi-mode cascade reaction, thereby producing an anti-tumor therapeutic effect with high efficiency and low side effects.
Owner:WUHAN UNIV

Xanthene nitroreductase-responsive fluorescent dye compound as well as preparation method and application thereof

The invention discloses a xanthene nitroreductase-responsive fluorescent dye compound as well as a preparation method and application thereof, and belongs to the technical field of xanthene derivatives. The fluorescent dye compound can be used for quickly and specifically recognizing overexpressed nitroreductase in tumor cells; after the fluorescent probe acts with nitroreductase, the fluorescence intensity of the fluorescent probe at 718 nm is obviously enhanced, and the fluorescent probe has excellent targeting capability on mitochondria; meanwhile, under the excitation of illumination with the specific wavelength of 660 nm, an acting product of the fluorescent dye compound and nitroreductase can efficiently generate reactive oxygen species (ROS), and then the effect of specifically killing tumor cells is achieved. The xanthene nitroreductase response type fluorescent dye compound provided by the invention can achieve the goal of integration of diagnosis and treatment of solid tumors, and has important clinical application value.
Owner:LULIANG UNIV

A method of increasing target radius in drilling

PendingCN122263205AReduce orientation errorsOptimize trajectoryGeometric CADFluid removalThermodynamicsDirectional well
The present application relates to the field of oil and gas field development research, and provides a method for improving target radius in drilling, comprising the following steps: step 1, determining the main layer of the target block, and determining the production capacity of the main layer; step 2, determining the sweet spot distribution of the well site deployment area based on at least the production capacity of the main layer, and determining the main layer plane and the longitudinal distribution trend of the main layer of the well site deployment area; step 3, determining the well point position based on at least the main layer plane and the longitudinal distribution trend of the main layer of the well site deployment area, and determining the well pattern; step 4, determining the target area range based on at least the well pattern, designing the target point, and designing the target point with the depth of the main layer as the target area range; and step 5, determining the directional well trajectory. The present application takes the depth of the main layer as the design target point, and considers the regular well pattern, so that the directional error of the well trajectory can be effectively reduced, the target accuracy can be improved, the well trajectory can be optimized, the footage can be further reduced, the drilling cycle can be shortened, the field operation efficiency can be improved, and the investment can be saved.
Owner:PETROCHINA CO LTD

Gene transcription framework, vector system, genome sequence editing method and application

The invention provides a gene transcription framework, a vector system, a genome sequence editing method and the application thereof. The gene transcription framework is based on a eukaryotic retrotransposition mechanism and can be mediated by a DNA, RNA or RNP pathway, and comprises the transcription production sequence comprising one or more upstream sequence of target site, a sequence to be inserted and a downstream sequence of target site, one or more SINE (element(s)), one or more LINE (element(s)), one or more ORF1p coding sequence(s) and / or one or more ORF2p coding sequence(s). According to the gene editing method, on the premise that foreign systems or substances are not introduced as much as possible and double-strand breaks are not generated, by transferring the gene editing system into nucleus or cytoplasm through a DNA, RNA or RNP pathway (RNA or RNP is transferred from cytoplasm to nucleus through ORF1p and / or ORF2p mediation), the target fragment is inserted into a designated site in a genome or the designated fragment in the genome is deleted or replaced, and high targeting accuracy is achieved.
Owner:PENG SHUANGHONG

A composition for treating diffuse large B-cell lymphoma of type ABC and its application.

This invention discloses a composition for treating ABC type diffuse large B-cell lymphoma and its application, belonging to the field of biomedical technology. The composition comprises chidamide and psyllium phosphate. This invention constructs a synergistic therapeutic system of chidamide and psyllium phosphate, precisely overcoming the treatment challenges of ABC type diffuse large B-cell lymphoma. By targeting the dual key targets of HDAC3 and PIM1, this composition achieves synergistic effects of epigenetic regulation and signaling pathway inhibition, significantly improving anti-tumor efficacy. This invention successfully overcomes the bottleneck of poor efficacy and high relapse rate of existing R-CHOP regimens in the treatment of ABC subtype lymphoma, providing a novel, highly specific treatment strategy for relapsed or refractory ABC type diffuse large B-cell lymphoma, with broad clinical application prospects.
Owner:BEIJING FRIENDSHIP HOSPITAL CAPITAL MEDICAL UNIV